Controlling Ice Nucleation During the Freezing Step of Lyophilization - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Controlling Ice Nucleation During the Freezing Step of Lyophilization
Lyophilization technologies for controlled nucleation.

Pharmaceutical Technology
Volume 37, Issue 5, pp. 36-40


1. ABB website, "Freeze Drying in the Pharmaceutical Industry,", accessed Apr. 9, 2013.

2. R. Bursac, R. Sever, and B. Hunek, BioProcess Int. 7 (9) 66-72 (2009).

3. K Scoffin and L Ciccolini, BioPharm Int. 26 (3) 46-51 (2013).

4. A. Hottot, S. Vessot, and J. Andrieu, Drying Technology 22 (8) 2009-2021 (2004).

5. M.L. Roy and M.J. Pikal, J Parenter. Sci. Technol. 43, 60–66 (1989).

6. J.A. Searles, J. F. Carpenter, and T.W. Randolph, J Pharm. Sci. 90, 860–871 (2001).

7. A.K. Konstantinidis et al, J Pharm. Sci. 100 (8) 3453-70 (2011).

8. P. Startzel, M. Gieseler, and H. Gieseler, "Rational Freeze-Drying Cycle Optimization Using Two Innovative Technologies: SMART Freeze-Dryer and ControLyo Nucleation On-Demand," presentation at the Controlled Release Society Germany Local Chapter Meeting (Wuerzburg, Mar., 2012).

9. G.A. Sacha and R. Sever, "Controlled Nucleation in Lyophilization: The Effects on Lyophilization Time and Physical Appearance of Lyophilized Pharmaceutical Excipients," presentation at the CPPR Freeze Drying of Pharmaceuticals & Biologicals Conference (Breckenridge, CO, Aug., 2012).

10. G.B. Strambini and E. Gabellieri, Biophys. J 70 (2) 971-976. (1996).

11. A. Millqvist-Fureby, M. Malmsten, and B. Bergenstahl, Int. J Pharm. 191 (2) 103-114 (1999).

12. B.S. Chang, B.S. Kendrick, and J.F. Carpenter, J Pharm. Sci. 85 (12) 1325–1330 (1996).

13. S. Jiang and S.L. Nail, Eur. J Pharm. Biopharm. 45 (3) 249-257 (1998).

14. M. Pikal, "Advances in Controlled Ice Nucleation," presentation at the PEP Talk Conference (Palm Springs, CA, Jan., 2013).

15. P. Chakravarty et al, BioPharm Int. 25 (1) 33-38 (2012).

16. P. Thomas, PharmaManufacturing website, "Controlled Ice Nucleation Moves into Manufacturing,", accessed Apr. 9, 2013.

17. J. Brower, "Ice Fog Induced Nucleation: A Case Study," presentation at the First Annual Lyo Summit: Lyophilization Conference (Garmisch-Partenkirchen, Germany, Oct., 2012).

18. R. Sever et al, "ControLyo Nucleation On-Demand Technology: New Case Studies and Manufacturing Scale Implementation," presentation at the PEP Talk Conference (SanDiego, Jan., 2012).

19. M. Shon and B. Uchil, "Scale-Up of Controlled Nucleation to a Production Environment," presentation at the PEP Talk Conference (Palm Springs, CA, Jan., 2013).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Pharmaceutical Technology,
Click here